Skip to main content

Pathology of Cushing’s Disease

  • Chapter
  • First Online:
Book cover Cushing's Disease

Part of the book series: Endocrine Updates ((ENDO,volume 31))

  • 1797 Accesses

Abstract

Adrenocorticotropin (ACTH)-producing pituitary adenomas are derived from corticotroph cells in the anterior pituitary gland. Most of them secrete excess ACTH leading to cortisol overproduction or Cushing’s disease. However, ACTH-producing pituitary tumors are heterogeneous and differ in histologic, immunohistochemical, and ultrastructural findings as well as in clinical presentations and prognosis. In this chapter, the histopathology of ACTH-producing adenomas and their clinicopathologic correlations are described.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lopes MBS, Pernicone PJ, Scheithauer BW, Horvath E, Kovacs K. Pituitary and sellar region. In: Mills SE, editor. Histology for pathologists. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2007. p. 321–44.

    Google Scholar 

  2. Raffin-Sanson ML, de Keyzer Y, Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol. 2003;149(2):79–90.

    Article  PubMed  CAS  Google Scholar 

  3. Lloyd RV, Kovacs K, Young Jr WF, et al. Tumours of the pituitary. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. World health organization classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC; 2004. p. 9–39.

    Google Scholar 

  4. Burger PC, Scheithauer BW, Vogel FS. Region of the sella turcica. In: Burger PC, Scheithauer BW, Vogel FS, editors. Surgical pathology of the nervous system and its coverings. 4th ed. Philadelphia, PA: Churchill Livingstone; 2002. p. 437–97.

    Google Scholar 

  5. Asa SL. Pituitary and suprasellar tumours. In: Love S, Louis DN, Ellison DW, editors. Greenfield’s neuropathology. 8th ed. London: Hodder Arnold; 2008. p. 2088–107.

    Google Scholar 

  6. George DH, Scheithauer BW, Kovacs K, et al. Crooke’s cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol. 2003;27(10):1330–6.

    Article  PubMed  Google Scholar 

  7. Banasiak MJ, Malek AR. Nelson syndrome: comprehensive review of pathophysiology, diagnosis, and management. Neurosurg Focus. 2007;23(3):E13.

    Article  PubMed  Google Scholar 

  8. Assie G, Bahurel H, Bertherat J, Kujas M, Legmann P, Bertagna X. The Nelson’s syndrome… revisited. Pituitary. 2004;7(4):209–15.

    Article  PubMed  Google Scholar 

  9. Karavitaki N, Ansorge O, Wass JA. Silent corticotroph adenomas. Arq Bras Endocrinol Metabol. 2007;51(8):1314–8.

    Article  PubMed  Google Scholar 

  10. Stefaneanu L, Kovacs K, Horvath E, Lloyd RV. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas. Virchows Arch A Pathol Anat Histopathol. 1991;419(2):107–13.

    Article  PubMed  CAS  Google Scholar 

  11. Tateno T, Izumiyama H, Doi M, et al. Differential gene expression in ACTH-secreting and non-functioning pituitary tumors. Eur J Endocrinol. 2007;157(6):717–24.

    Article  PubMed  CAS  Google Scholar 

  12. Ohta S, Nishizawa S, Oki Y, Yokoyama T, Namba H. Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I–immunohistochemical study. Pituitary. 2002;5(4):221–3.

    Article  PubMed  CAS  Google Scholar 

  13. Tateno T, Izumiyama H, Doi M, Akashi T, Ohno K, Hirata Y. Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma. Endocr J. 2007;54(5):777–82.

    Article  PubMed  CAS  Google Scholar 

  14. Utz AL, Swearingen B, Biller BM. Pituitary surgery and postoperative management in Cushing’s disease. Endocrinol Metab Clin North Am. 2005;34(2):459–78. xi.

    Article  PubMed  Google Scholar 

  15. Kelly DF. Transsphenoidal surgery for Cushing’s disease: a review of success rates, remission predictors, management of failed surgery, and Nelson’s Syndrome. Neurosurg Focus. 2007;23(3):E5.

    Article  PubMed  Google Scholar 

  16. Gejman R, Swearingen B, Hedley-Whyte ET. Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Hum Pathol. 2008;39(5):758–66.

    Article  PubMed  CAS  Google Scholar 

  17. Saeger W, Ludecke B, Ludecke DK. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas. Exp Clin Endocrinol Diabetes. 2008;116(2):80–5.

    Article  PubMed  CAS  Google Scholar 

  18. Hsu DW, Hakim F, Biller BM, et al. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg. 1993;78(5):753–61.

    Article  PubMed  CAS  Google Scholar 

  19. Kaltsas GA, Nomikos P, Kontogeorgos G, Buchfelder M, Grossman AB. Clinical review: diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab. 2005;90(5):3089–99.

    Article  PubMed  CAS  Google Scholar 

  20. van der Klaauw AA, Kienitz T, Strasburger CJ, Smit JW, Romijn JA. Malignant pituitary corticotroph adenomas: report of two cases and a comprehensive review of the literature. Pituitary. 2009;12(1):57–69.

    Article  PubMed  Google Scholar 

  21. Thapar K, Kovacs K, Scheithauer BW, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery. 1996;38(1):99–107.

    Article  PubMed  CAS  Google Scholar 

  22. Hosaka N, Kitajiri S, Hiraumi H, et al. Ectopic pituitary adenoma with malignant transformation. Am J Surg Pathol. 2002;26(8):1078–82.

    Article  PubMed  Google Scholar 

  23. Tanizaki Y, Jin L, Scheithauer BW, Kovacs K, Roncaroli F, Lloyd RV. P53 gene mutations in pituitary carcinomas. Endocr Pathol. 2007;18(4):217–22.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. T. Hedley-Whyte .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Cheunsuchon, P., Hedley-Whyte, E.T. (2011). Pathology of Cushing’s Disease. In: Swearingen, B., Biller, B. (eds) Cushing's Disease. Endocrine Updates, vol 31. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0011-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-0011-0_3

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-0010-3

  • Online ISBN: 978-1-4614-0011-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics